Biocartesian
Converting biology into digital molecular maps
Biocartesian operates in healthcare based in San Francisco, CA, USA.
Profile
Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.
Its activity falls under healthcare; the profile below is assembled from public directory data.
The business is associated with San Francisco, CA, USA.
It is recorded at the Summer 2024 stage.
Its team size is recorded as 2 employees.
Directory analysis
Biocartesian develops high‑resolution molecular imaging tools that combine advanced microscopy with novel chemistries, enabling visualization of 50‑times more molecules in diseased tissues than current methods. The platform produces digital molecular maps that help researchers identify abnormal molecules and their locations for drug discovery and disease biology studies.
Positioning: The company is positioned in the niche of molecular diagnostics and imaging, targeting academic, pharmaceutical, and biotech research markets that require detailed spatial molecular data. Its technology addresses a key limitation in current imaging by dramatically increasing observable molecular content.
Note: Biocartesian provides high‑resolution molecular imaging for disease research.
Auto-generated directory analysis from public data · updated 11 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Summer 2024 |
Website: www.biocartesian.com
Browse related
Create a free account